Moneta Group Investment Advisors LLC Bio N Tech Se Transaction History

Moneta Group Investment Advisors LLC

  • $9.24 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$113.32 - $241.49 $485,689 - $1.04 Million
-4,286 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$85.73 - $119.5 $428 - $597
5 Added 0.12%
4,286 $468,000
Q4 2020

Feb 12, 2021
BUY
$72.71 - $129.54 $311,271 - $554,560
4,281 New
4,281 $349,000
Q3 2020

Nov 13, 2020
SELL
$57.81 - $104.17 $374,608 - $675,021
-6,480 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$38.58 - $66.74 $249,998 - $432,475
6,480 New
6,480 $431,000

Others Institutions Holding BNTX

# of Institutions
357
Shares Held
38.4M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.7B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Moneta Group Investment Advisors LLC Portfolio

Follow Moneta Group Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email